PlantForm Corporation

PlantForm Corporation is a Canadian company with a proprietary technology that can reduce the high cost of life saving antibody drugs.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Toronto, ON, Canada
  • Currency CAD
  • Founded April 2008
  • Employees 12
  • Website plantformcorp.com

Company Summary

PlantForm's mission is to use our proprietary plant-based manufacturing technology to produce low-cost subsequent entry biologic (SEB) antibody drugs to help people fight cancer and other critical illness. Our first product will be a SEB version of the breast-cancer drug Herceptin ($6 billion annual sales), the brand name for trastuzumab.

Team

  • Don Stewart
    CEO

    Dr. Don Stewart is an entrepreneur and scientist with more than 20 years of management experience in the biotechnology industry.

  • Ron Hosking
    CFO

    Mr. Ron Hosking is a chartered accountant with three decades of experience as a financial manager in the biotechnology and pharmaceutical industries.

  • J.Christopher Hall
    CSO

    Dr. Chris Hall is a professor and Canada Research Chair in Recombinant Antibody Technology in the School of Environmental Sciences at the University of Guelph.

  • David Cayea

Advisors

  • Gowling Lafleur Henderson LLP
    Lawyer
    Unconfirmed
    BDO Canada
    Accountant
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free